Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis

Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02468479

Enrollment

200

Registered

2015-06-10

Start date

2015-06-30

Completion date

2016-12-31

Last updated

2017-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Keywords

Liver cirrhosis

Brief summary

Chest/abdominal wall varices and spider nevi are two common presenting signs of liver cirrhosis. Their prognostic values remain unclear.

Interventions

OTHERNo relevant intervention.

No relevant intervention.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Liver cirrhosis. 2. Consecutive admission. 3. Permitted to physical examinations. 4. Informed consents.

Exclusion criteria

1. Non-cirrhotic portal hypertension. 2. Malignancy. 3. Uncontrolled infection. 4. Severe chronic diseases. 5. Poor patient compliance.

Design outcomes

Primary

Measure	Time frame	Description
Prevalence and type of chest/abdominal wall varices and spider nevi	1.5 years	Baseline data
Association between etiology of liver cirrhosis and type of chest/abdominal wall varices and spider nevi	1.5 years	Baseline data
Association between degree of liver function and type of chest/abdominal wall varices and spider nevi	1.5 years	Baseline data
Effect of chest/abdominal wall varices and spider nevi on survival	2.5 years or more	Follow-up data

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026